A shear-thinning therapeutic composition is provided along with methods of making and using the therapeutic composition.

A shear-thinning therapeutic composition is provided along with methods of making and using the therapeutic composition.

The invention relates to a method for producing an implant which contains a composite powder comprising microstructured particles, obtainable by a method in which large polymer particles are bonded to small spherical calcium carbonate particles. Said calcium carbonate particles can be obtained by a method with the following steps: a) providing a calcium hydroxide suspension, b) introducing carbon dioxide or a carbon dioxide-containing gas mixture into the suspension from step a), and c) separating the calcium carbonate particles formed, while adding 0.3 wt.-% to 0.7 wt.-% of at least one amino trialkylene phosphonic acid.

The invention relates to a method for producing an implant which contains a composite powder comprising microstructured particles, obtainable by a method in which large polymer particles are bonded to small spherical calcium carbonate particles. Said calcium carbonate particles can be obtained by a method with the following steps: a) providing a calcium hydroxide suspension, b) introducing carbon dioxide or a carbon dioxide-containing gas mixture into the suspension from step a), and c) separating the calcium carbonate particles formed, while adding 0.3 wt.-% to 0.7 wt.-% of at least one amino trialkylene phosphonic acid.

A solid state method of producing inorganic nanoparticles using glass is disclosed. The nanoparticles may not be formed until the glass is reacted with or degraded by contact with a fluid in vivo or in vitro.

A composite powder containing microstructured particles obtainable by means of a method in which large particles are combined with small particles, wherein the large particles have an average particle diameter within the range from 0.1 m to 10 mm, the large particles comprise at least one polymer, the small particles are arranged on the surface of the large particles and/or distributed inhomogeneously within the large particles, the small particles comprise sphere-shaped precipitated calcium carbonate particles having an average diameter within the range from 0.05 m to 50.0 m, wherein the sphere-shaped calcium carbonate particles are obtainable by means of a method in which
a. a calcium hydroxide suspension is initially charged,
b. carbon dioxide or a carbon dioxide-containing gas mixture is introduced into the suspension from step a. and
c. resultant calcium carbonate particles are separated off,
with 0.3% by weight to 0.7% by weight of at least one aminotrisalkylenephosphonic acid being further added.

Preferred application areas of the composite powder encompass its use as additive, especially as polymer additive, as additive substance or starting material for compounding, for the production of components, for applications in medical technology and/or in microtechnology and/or for the production of foamed articles.

The invention therefore also provides components obtainable by selective laser sintering of a composition comprising a composite powder according to the invention, except for implants for uses in the field of neurosurgery, oral surgery, jaw surgery, facial surgery, neck surgery, nose surgery and ear surgery as well as hand surgery, foot surgery, thorax surgery, rib surgery and shoulder surgery.

The invention also provides the sphere-shaped calcium carbonate particles which can advantageously be used to produce the composite particles according to the invention, and the use thereof.

A composite powder containing microstructured particles obtainable by means of a method in which large particles are combined with small particles, wherein the large particles have an average particle diameter within the range from 0.1 m to 10 mm, the large particles comprise at least one polymer, the small particles are arranged on the surface of the large particles and/or distributed inhomogeneously within the large particles, the small particles comprise sphere-shaped precipitated calcium carbonate particles having an average diameter within the range from 0.05 m to 50.0 m, wherein the sphere-shaped calcium carbonate particles are obtainable by means of a method in which
a. a calcium hydroxide suspension is initially charged,
b. carbon dioxide or a carbon dioxide-containing gas mixture is introduced into the suspension from step a. and
c. resultant calcium carbonate particles are separated off,
with 0.3% by weight to 0.7% by weight of at least one aminotrisalkylenephosphonic acid being further added.

Preferred application areas of the composite powder encompass its use as additive, especially as polymer additive, as additive substance or starting material for compounding, for the production of components, for applications in medical technology and/or in microtechnology and/or for the production of foamed articles.

The invention therefore also provides components obtainable by selective laser sintering of a composition comprising a composite powder according to the invention, except for implants for uses in the field of neurosurgery, oral surgery, jaw surgery, facial surgery, neck surgery, nose surgery and ear surgery as well as hand surgery, foot surgery, thorax surgery, rib surgery and shoulder surgery.

The invention also provides the sphere-shaped calcium carbonate particles which can advantageously be used to produce the composite particles according to the invention, and the use thereof.

This invention is directed to aragonite and calcite hydrogel biomatrices, optionally seeded with precursor cells and uses thereof in tissue engineering, regeneration and repair, including in inducing or enhancing bone formation, cartilage formation or a combination thereof in a subject, and kits related thereto.

Provided herein are methods for treating, adhering, or sealing biological tissue with a material, such as a hydrogel, that may include phyllosilicate nanoplatelets. The phyllosilicate nanoplatelets can have a high aspect ratio, a low aspect ratio, or be a mixture of high aspect ratio and low aspect ratio nanoplatelets. Drug releasing compositions and kits also are provided herein.

Methods of forming antimicrobial resin compositions comprising silver nanoparticles are disclosed, wherein the resin compositions that are generated exhibit lower initial color, reduced color shift upon storage and reduced levels of spontaneous polymerization. Such methods generally comprise: combining a silver-containing material with a self-cure and dual-cure base resin in situ wherein the base resin does not contain a catalytic amine; and adding a catalytic resin to the mixture of the resin and silver-containing material in order to form the final cured resin. Antimicrobial polymeric materials formed by said methods are also disclosed.